Multiple schemes of Motilal Oswal Mutual Fund have recently increased their collective stake in Healthcare Global Enterprises Ltd, a move that pushes their total shareholding above the 5% mark. This acquisition, completed on October 29, 2025, has been reported under SEBI substantial acquisition regulations.

Acquisition Details

The mutual fund schemes acquired an additional 1,54,556 shares of Healthcare Global Enterprises through market transactions. This strategic move has resulted in an increase in their collective holding from 4.93% to 5.04% of the company's total share capital.

Transaction Specifics

• Date of Acquisition: October 29, 2025
• Mode of Acquisition: Market Transactions
• Total Equity Share Capital: 14,10,00,100 shares (Face value of Rs. 10 each)

Participating Schemes

The acquisition was carried out by multiple schemes of Motilal Oswal Mutual Fund, including:

1. Motilal Oswal Balanced Advantage Fund
2. Motilal Oswal S And P BSE Healthcare ETF
3. Motilal Oswal Nifty Microcap 250 Index Fund
4. Motilal Oswal Multi Cap Fund
5. Motilal Oswal Business Cycle Fund
6. Motilal Oswal Infrastructure Fund
7. Motilal Oswal Active Momentum Fund
8. Motilal Oswal Special Opportunities Fund
9. Motilal Oswal BSE 1000 Index Fund
10. Motilal Oswal Services Fund
11. Motilal Oswal Consumption Fund

Regulatory Compliance

The transaction has been reported in compliance with SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Motilal Oswal Asset Management Company Limited, as the investment manager to Motilal Oswal Mutual Fund, has duly informed the stock exchanges about this acquisition.

This move by Motilal Oswal Mutual Fund indicates their investment decision regarding Healthcare Global Enterprises, a company listed on both the BSE Limited and the National Stock Exchange of India Limited.

Healthcare Global Enterprises Limited (HCG) has witnessed a significant change in its shareholding structure as Aceso Company Pte. Ltd. divested a substantial portion of its stake in the company. The Singapore-based entity sold 79,66,310 equity shares, representing approximately 5.65% of HCG's total share capital, through on-market transactions.

Transaction Details

The sale was executed over two consecutive days:

• September 10: 79,41,913 shares
• September 11: 24,397 shares

Following this transaction, Aceso Company's holding in Healthcare Global Enterprises has dramatically reduced from approximately 5.72% to 0.006%, retaining only 8,991 shares.

Regulatory Compliance

The company disclosed this transaction in compliance with the Securities and Exchange Board of India (SEBI) regulations for substantial acquisition of shares and takeovers. The disclosure was made to both the National Stock Exchange of India and BSE Limited, where Healthcare Global Enterprises is listed.

Impact on Shareholding

Company Updates

In related news, Healthcare Global Enterprises has made two significant announcements:

1. Employee Stock Option Allotment: The company's Board of Directors approved the allotment of 15,84,730 equity shares under its Employee Stock Option Schemes. This allotment has increased the company's paid-up share capital to INR 141,00,01,000, consisting of 14,10,00,100 equity shares of INR 10 each.

2. Senior Management Appointment: The company has appointed Mr. Gopi Lama as the Head of Domestic Sales. Mr. Lama brings over 30 years of experience in the healthcare sector, including significant expertise in hospital operations, market expansion, and business development.

These developments showcase Healthcare Global Enterprises' commitment to employee incentivization and strategic growth in the competitive healthcare market.

Healthcare Global Enterprises Limited, known for its specialization in cancer care, continues to evolve its business strategy and corporate structure. The recent share sale by Aceso Company Pte. Ltd. marks a significant shift in the company's ownership landscape, potentially opening doors for new investors or strategic partnerships in the future.